{"id":"https://openalex.org/W2890170672","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4148","title":"A phase I/II study of fosbretabulin in combination with everolimus in neuroendocrine tumors that have progressed after at least one prior regimen for metastatic disease.","display_name":"A phase I/II study of fosbretabulin in combination with everolimus in neuroendocrine tumors that have progressed after at least one prior regimen for metastatic disease.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2890170672","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4148","mag":"2890170672"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.tps4148","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4148","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4148","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051388864","display_name":"Aman Chauhan","orcid":"https://orcid.org/0009-0003-0136-1983","observed_orcids":["https://orcid.org/0009-0003-0136-1983","https://orcid.org/0000-0002-4183-2116"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aman Chauhan","raw_affiliation_strings":["University of Kentucky, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kentucky, Lexington, KY;","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030064179","display_name":"Susanne M. Arnold","orcid":"https://orcid.org/0000-0001-6542-9551","observed_orcids":["https://orcid.org/0000-0001-6542-9551"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susanne Arnold","raw_affiliation_strings":["University of Kentucky, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kentucky, Lexington, KY;","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081279720","display_name":"Stacey A. Slone","orcid":"https://orcid.org/0000-0002-4355-7672","observed_orcids":["https://orcid.org/0000-0002-4355-7672"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]},{"id":"https://openalex.org/I2802239656","display_name":"Markey Cancer Center","ror":"https://ror.org/01dhvva97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285210727","https://openalex.org/I143302722","https://openalex.org/I2802239656"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stacey A. Slone","raw_affiliation_strings":["University of Kentucky Markey Cancer Center, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kentucky Markey Cancer Center, Lexington, KY;","institution_ids":["https://openalex.org/I143302722","https://openalex.org/I2802239656"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Heather Flynn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather Flynn","raw_affiliation_strings":["University of Kentucky, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kentucky, Lexington, KY;","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023436882","display_name":"Heidi L. Weiss","orcid":"https://orcid.org/0009-0002-0980-7778","observed_orcids":["https://orcid.org/0009-0002-0980-7778"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]},{"id":"https://openalex.org/I2802239656","display_name":"Markey Cancer Center","ror":"https://ror.org/01dhvva97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285210727","https://openalex.org/I143302722","https://openalex.org/I2802239656"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heidi Weiss","raw_affiliation_strings":["University of Kentucky and Markey Cancer Center, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kentucky and Markey Cancer Center, Lexington, KY;","institution_ids":["https://openalex.org/I143302722","https://openalex.org/I2802239656"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005448318","display_name":"Lowell Brian Anthony","orcid":"https://orcid.org/0000-0001-7348-7874","observed_orcids":["https://orcid.org/0000-0001-7348-7874"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lowell Brian Anthony","raw_affiliation_strings":["University of Kentucky, Lexington, KY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Kentucky, Lexington, KY;","institution_ids":["https://openalex.org/I143302722"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"TPS4148","last_page":"TPS4148"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":0.9990000128746033},{"id":"https://openalex.org/keywords/gastroenteropancreatic-neuroendocrine-tumors","display_name":"gastroenteropancreatic neuroendocrine tumors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/metastatic-neuroendocrine-tumors","display_name":"metastatic neuroendocrine tumors","score":0.8970000147819519},{"id":"https://openalex.org/keywords/vascular-disrupting-agents","display_name":"vascular disrupting agents","score":0.9679999947547913},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5809999704360962},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9240000247955322},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6809999942779541},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.7039999961853027},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6460000276565552}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9213855862617493},{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.8779661655426025},{"id":"https://openalex.org/C2779066768","wikidata":"https://www.wikidata.org/wiki/Q1981276","display_name":"Neuroendocrine tumors","level":2,"score":0.7753391265869141},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.7138348817825317},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5490595698356628},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5101644992828369},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.43586379289627075},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.28679150342941284}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.tps4148","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4148","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.tps4148","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2954986240","https://openalex.org/W2947085753","https://openalex.org/W3010499233","https://openalex.org/W4406869238","https://openalex.org/W4251977102","https://openalex.org/W2796335748","https://openalex.org/W2103077135","https://openalex.org/W2898206761","https://openalex.org/W2243071171","https://openalex.org/W4415942653"],"abstract_inverted_index":{"TPS4148":[0],"Background:":[1],"Gastroenteropancreatic":[2],"neuroendocrine":[3,40,170,203],"tumors":[4,41,204],"(GEPNETs)":[5],"are":[6,42],"rare":[7],"tumors.":[8],"Recent":[9],"SEER":[10],"database":[11],"analysis":[12],"shows":[13],"consistent":[14],"surge":[15],"in":[16,78,95,202],"the":[17,27,33,52,63,66,75,149,191,196,225],"incidence":[18],"of":[19,25,29,51,65,81,104,138,151,173,195,198,221,224],"GEPNETs.":[20,99],"Due":[21],"to":[22,189,228],"indolent":[23],"nature":[24],"GEPNETs":[26],"prevalence":[28],"disease":[30],"far":[31],"exceeds":[32],"incidence.":[34],"Treatment":[35],"options":[36],"for":[37,214],"metastatic":[38,215],"progressive":[39],"expanding.":[43],"Fosbretabulin":[44,73,242],"is":[45,74,106,157,188],"a":[46,79,125,174],"synthetic,":[47],"water-soluble,":[48],"phosphorylated":[49],"prodrug":[50],"natural":[53],"product":[54],"Combretastatin":[55],"A4":[56],"(CA4P),":[57],"which":[58],"was":[59],"originally":[60],"isolated":[61],"from":[62],"bark":[64],"South":[67],"African":[68],"bush":[69],"willow,":[70],"Combretum":[71],"caffrum.":[72],"lead":[76],"compound":[77],"class":[80],"agents":[82,86,133],"termed":[83],"vascular":[84],"disrupting":[85],"(VDAs)":[87],"and":[88,98,123,147,200,227,230],"has":[89,124,148],"shown":[90],"activity":[91],"as":[92],"single":[93,161],"agent":[94],"ovarian":[96],"cancers":[97],"Rationale:":[100],"The":[101],"vasoconstrictive":[102],"effect":[103],"fosbretabulin":[105,201],"potent,":[107],"though":[108],"short-lived":[109],"(4-8":[110],"hours),":[111],"with":[112,134,238],"no":[113],"cumulative":[114],"adverse":[115],"effect.":[116],"Everolimus":[117],"inhibits":[118],"angiogenesis,":[119],"slows":[120],"tumor":[121,142],"growth":[122],"prolonged":[126],"half-life":[127],"(30":[128],"hours).":[129],"Combining":[130],"these":[131],"two":[132],"distinctly":[135],"different":[136],"mechanisms":[137],"action":[139],"may":[140],"improve":[141],"control":[143],"without":[144],"additional":[145],"toxicities,":[146],"potential":[150],"reducing":[152],"drug":[153],"resistance.":[154],"Methods:":[155],"This":[156],"an":[158,181],"investigator":[159],"initiated,":[160],"center,":[162],"open":[163],"label,":[164],"phase":[165],"I/II":[166],"study":[167],"involving":[168],"gastroenteropancreatic":[169],"tumors,":[171],"consisting":[172],"dose":[175,194],"escalation":[176],"Part":[177,184],"A":[178],"followed":[179],"by":[180],"expansion":[182],"cohort":[183],"B.":[185],"Primary":[186],"Objective":[187],"establish":[190],"maximum":[192],"tolerated":[193],"combination":[197,226],"everolimus":[199],"that":[205],"have":[206],"progressed":[207],"after":[208],"at":[209],"least":[210],"one":[211],"prior":[212],"regimen":[213],"disease.":[216],"Secondary":[217],"Objectives":[218],"include":[219],"evaluation":[220],"safety":[222],"profile":[223],"observe":[229],"record":[231],"anti-tumor":[232],"activity.":[233],"Patients":[234],"will":[235,243],"be":[236,244],"treated":[237],"daily":[239],"oral":[240],"everolimus.":[241],"administered":[245],"IV":[246],"either":[247],"q3":[248],"weekly":[249,252],"or":[250],"q":[251],"based":[253],"on":[254],"partial":[255],"order":[256],"continuous":[257],"reassessment":[258],"model":[259],"(PO":[260],"CRM).":[261],"Clinical":[262],"trial":[263],"information:":[264],"NCT03014297.":[265]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2018-09-27T00:00:00"}